Cell Free DNA in Mature B-cell Lymphoma
The purpose of this study is to assess whether plasma cell free DNA is an accurate tool that can early and dynamically inform on treatment outcome and an accessible source of tumor DNA to track tumor clonal evolution.
| Condition(s) | Mature B-Cell Lymphoma |
|---|---|
| Status | Recruiting |
| Study type | Observational |
| Summary | The purpose of this study is to assess whether plasma cell free DNA is an accurate tool that can early and dynamically inform on treatment outcome and an accessible source of tumor DNA to track tumor clonal evolution. |
| Who can participate | Inclusion Criteria: * Documented diagnosis of mature B-cell tumor according to WHO 2008 criteria * 18 years or older Exclusion Criteria: * Chemotherapy before * Other tumors |
| Ages | 18 Years |
| Sex | All |
| Lead sponsor | Ruijin Hospital |
| Locations | Shanghai, Shanghai Municipality, China |
| Start date | 2022-09-28 |
| NCT ID | NCT04088422 |
| Official listing | https://clinicaltrials.gov/study/NCT04088422 |